Forvis Mazars Wealth Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Forvis Mazars Wealth Advisors, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $90.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$90.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 42,462 | $39.1M |
| JNJJOHNSON & JOHNSON | 56,691 | $13.9M |
| MCKMcKesson Corporation | 7,695 | $6.7M |
| MRKMerck & Co., Inc. | 49,228 | $5.9M |
| ABBVAbbVie Inc. | 26,809 | $5.8M |
| INCYIncyte Corp. | 47,373 | $4.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,042 | $2.4M |
| ABTABBOTT LABORATORIES | 21,082 | $2.2M |
| PMPhilip Morris International Inc | 12,810 | $2.1M |
| ELVElevance Health Inc. | 7,101 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 25,053 | $1.5M |
| PFEPFIZER INC | 45,499 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,862 | $775K |
| AMGNAMGEN INC | 2,186 | $769K |
| AZNASTRAZENECA PLC | 2,306 | $455K |
| ZBHZimmer Biomet Holdings Inc. | 4,297 | $389K |
| GILDGILEAD SCIENCES, INC. | 2,448 | $341K |
| CORCencora Inc. | 969 | $304K |
| NVSNovartis AG | 1,924 | $294K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 518 | $231K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.